Low-dose Bacillus Calmette-Guerin versus full-dose for intermediate and high-risk of non-muscle invasive bladder cancer: a Markov model

BACKGROUND: To compare the efficacy of low dose (27 mg) Bacillus Calmette-Guérin (BCG) and a full dose (81 mg) BCG immunotherapy for patients with intermediate and high-risk non-muscle invasive bladder cancer (NMIBC) after a typical transurethral bladder resection. METHODS: We constructed a Markov m...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:BMC Cancer
Autori principali: Wang, Zongren, Xiao, Han, Wei, Guangyan, Zhang, Ning, Wei, Mengchao, Chen, Zebin, Peng, Zhenwei, Peng, Sui, Qiu, Shaopeng, Li, Heping, Long, Jianting
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2018
Soggetti:
Research Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6233591/
https://ncbi.nlm.nih.gov/pubmed/30419836
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-4988-z
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi